Stockreport

IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update

Imunon, Inc.  (IMNN) 
PDF R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first fr [Read more]